Hedy Teppler - Articles and news items

Merck logo

Merck receives FDA approval for ISENTRESS® (raltegravir) for pediatric oral suspension

Industry news / 8 January 2014 / Merck

ISENTRESS is now indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in patients four weeks of age and older…

Merck logo

FDA approves Merck’s ISENTRESS® (raltegravir)

Industry news, News / 6 January 2012 / Merck

The U.S. FDA recently approved the use of ISENTRESS® (raltegravir) in combination with other antiretroviral (ARV) medicines…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...